Patents
Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
04/2004
04/29/2004US20040082572 Benzodiazepine derivatives as app modulators
04/29/2004CA2502249A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
04/28/2004EP1412325A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
04/28/2004CN1147483C Adamantane derivatives
04/22/2004WO2004033436A1 Sulfonylbenzodiazepinone acetamides as bradykinin antagonists
04/22/2004WO2004032930A1 Method of treatment for cancer
04/22/2004CA2501801A1 Sulfonylbenzodiazepinone acetamides as bradykinin antagonists
04/21/2004EP1409468A2 Guanidinobenzamides as mc4-r agonists
04/21/2004CN1491207A Acylated indanyl amines and their use as pharmaceuticals
04/21/2004CN1146551C Substituted diazacycloheptane compound, medicine composition contg, same and the use thereof
04/15/2004US20040072823 Central nervous system disorders; analgesics; antiinflammatory agents
04/15/2004US20040072822 N,N-disubstituted diazocycloalkanes
04/14/2004EP1406884A1 Arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
04/08/2004WO2003082832A3 Anxiolytic agents with reduced sedative and ataxic effects
04/08/2004US20040068109 Activated blood coagulation factor X inhibitor and also to such a pharmaceutical agent and particularly has an excellent activity by oral administration
04/07/2004CN1487940A Lactam compounds and medicinal use thereof
04/07/2004CN1144793C Polar-substituted hydrocarbons
04/07/2004CN1144788C Bicycle vasporession agonists
04/06/2004US6717014 Reacting amines with alpha-, omega - dihaloalkanes or alkenes; low cost; safe
04/01/2004WO2004026843A1 Benzodiazepine derivatives and pharmaceutical compositions containing them
04/01/2004WO2003062819A3 Water- soluble derivatives of lipophilic drugs
04/01/2004WO2002076402A3 Fatty amine drug conjugates
03/2004
03/31/2004CN1143854C Novel 2-(iminomethyl) amino-phenyl derivatives,the preparation thereof, application as medicines and pharmaceutical compositions containing same
03/30/2004US6713476 Substituted cycloalkyls as inhibitors of a beta protein production
03/25/2004WO2003004480A3 Substituted piperazine and diazepanes as histamine h3 receptor agonists
03/25/2004US20040058913 Cyclic diamine compound with condensed-ring groups
03/25/2004US20040058912 Psychological disorders; eating disorders; dietetics
03/24/2004EP1400510A1 Cyclic diamine compounds having fused-ring groups
03/24/2004EP1399444A2 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
03/23/2004US6710058 Use as anticoagulant agents for therapy and prophylaxis ofthromboembolic disorders
03/18/2004WO2004022563A1 Benzotriazabicyclic derivatives and use thereof as beta-lactamase inhibitors and anti-bacterial agents
03/18/2004US20040053925 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
03/18/2004US20040053919 Administering a patient suffering from arthritic diseases, a 1,4-benzodiazapine or a 1,4-benzothiazepine derivative for treating such degenerative joint diseases
03/18/2004US20040053918 Erythropoietin production potentiator
03/18/2004US20040053907 Cell adhesion inhibitors
03/17/2004EP1398033A2 Use of benzodiazepines for treating autoimmune diseases, inflammations, neoplasies, viral infections and atherosclerosis
03/17/2004EP1224175B1 Benzodiazepine derivatives as metabotropic glutamate receptor antagonists
03/17/2004EP1140936B1 Tricyclic inhibitors of poly(adp-ribose) polymerases
03/17/2004CN1483028A Quinolinone derivatives as tyrosine kinase inhibitors
03/16/2004US6706765 Aminoguanidines and alkoxyguanidines as protease inhibitors
03/16/2004CA2096460C Dual action inhibitors
03/11/2004WO2004019946A1 Inhibitors for excessive accumulation of sodium ion in cells
03/11/2004WO2003091264A3 Non nucleoside reverse transcriptase inhibitors
03/11/2004WO2002076404A3 Fatty alcohol drug conjugates
03/11/2004US20040048897 Il-8 receptor antagonists
03/11/2004US20040048853 Compounds, compositions, and methods
03/11/2004US20040048847 Increasing the sugar-transporting capacity; preventing and/or treating diabetes, diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic macroangiopathy, impaired glucose tolerance or adiposis
03/10/2004CN1481380A Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
03/10/2004CN1481376A Oxybenzamides derivatives as factor xa inhibitors
03/09/2004US6703403 Method for improving pharmacokinetics
03/09/2004US6703387 Inhibitors of HPV E1 helicase enzyme
03/04/2004WO2004018058A2 Compounds, compositions, and methods
03/04/2004US20040044199 Cyclic urea compounds and preparation thereof
03/03/2004EP1394242A2 Cyclic thioureas and their use as additives for lubricating oils
03/03/2004EP1392663A2 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
03/03/2004EP1307460B1 METHOD FOR THE PRODUCTION OF IMIDAZO-[1,2-c][2,3]-BENZODIAZEPINES AND INTERMEDIATES IN THE PRODUCTION THEREOF
03/03/2004CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor
02/2004
02/26/2004US20040038962 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia
02/25/2004EP1391203A1 Antitumor agents
02/19/2004US20040034104 2,2-Diphenylbutanamide derivatives and medicines containing the same
02/19/2004US20040034018 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders
02/19/2004US20040033986 Anti tubercular drug: compositions and methods
02/18/2004EP1389204A1 Novel sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same
02/18/2004EP1389194A2 Inhibitors of bace
02/18/2004EP1389189A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
02/18/2004CN1476446A Benzodiazepine derivative
02/12/2004WO2004012648A2 Substituted diaryl heterocycles, method for the production and use thereof as medicaments
02/12/2004US20040029865 Bis-arylsulfones
02/12/2004US20040029742 Bicyclic thioureas as additives for lubricating oils
02/12/2004DE10233817A1 Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted Diarylheterocyclen, processes for their preparation and their use as medicaments
02/10/2004US6689881 Method for preparing substituted [1,4]diazepino[6,7,1-hi]indol-4-ones
02/05/2004WO2004011438A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect
02/05/2004US20040024203 Imines such as 4-(3-((3-(2,4-dichlorophenyl)propanoyl)amino)-1-(3-(morpholin-4-yl)propyl)-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-5-yl)benzamide, administered for prophylaxis of Alzheimer's disease
02/05/2004CA2493924A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect
02/03/2004US6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
02/03/2004US6686350 Cell adhesion inhibitors
01/2004
01/29/2004WO2003053366A3 Pyrimidine a2b selective antagonist compounds, their synthesis and use
01/29/2004US20040019117 Anti tubercular drug: compostions and methods
01/29/2004US20040019041 Method for the production of imidazo-(1,2-C)(2,3)-benzodiazepines and intermediates in the production thereof
01/29/2004US20040019039 Substituted piperazines and diazepanes
01/28/2004EP1143946B1 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
01/28/2004CN1135982C Process for preparing pharmaceutical composition containing N-acyl-2,3-benzodiazepine deriratives
01/27/2004US6683074 Cyclic amine derivatives-CCR-3 receptor antagonists
01/22/2004US20040014971 N-(4-(4-(2-oxo-1-phenyl-2-((2,2,2-trifluoroethyl)amino)ethyl)-1 -piperazinyl)-phenyl)-4'-(trifluoromethyl)-(1,1'-biphenyl)-2-carboxamide for treatment of obesity, diabetes, and cardiovascular disorders; decreases apoplioprotein secretion
01/22/2004US20040014966 Such as 2-(phenylsulfonyl)-5-(1-piperazinyl)phenylamine which is a 5-HT receptor ligand; for performing positron emission tomography, nuclear magnetic resonance
01/22/2004US20040013720 Receptor antagonist-lipid conjugates and delivery vehicles containing same
01/21/2004EP1381608A1 Cyclohexylphenyl vasopressin agonists
01/21/2004EP1381370A1 N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists
01/21/2004CN1469862A 2,2-diphenyl butanamide derivatives and medicines containing the same
01/20/2004US6680317 N-(phenyl)-n*-(2-hydroxy-3-aminosulfonylphenyl)guanidine derivatives; chemokine inhibitors; respiratory, cardiovascular, rheumatic, brain, and nervous system disorders
01/20/2004US6680312 Sulfonamide derivatives, their production and use
01/15/2004WO2003041658A3 Process for the preparation of 3,7-disubstituted-2,3,4,5- tetrahydro-1h-1,4-benzodiazepine compounds
01/15/2004US20040009972 Benzodiazepine inhibitors of mitochondial F1F0 ATP hydrolase and methods of inhibiting F1F0 ATP hydrolase
01/14/2004EP1379522A1 DIHYDRO-BENZO(b)(1,4)DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I
01/14/2004EP1379511A1 DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II
01/14/2004EP1379493A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
01/14/2004CN1134423C Adhesion receptor antagonists
01/13/2004US6677332 Amide-substituted piperidine or azepine derivatives to treat drug abuse and tinnitus
01/08/2004WO2004002493A1 Erythropoietin production potentiator
01/08/2004US20040006142 Ocular tension depressor
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 60